MedPath

Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia

Completed
Conditions
Cervical Neoplasia
Cervical Cancer
Registration Number
NCT02253719
Lead Sponsor
Sihanouk Hospital Center of HOPE
Brief Summary

The prevalence of cervical neoplasia in Cambodia is not known. There are no screening programs in place. The investigators plan on introducing a screening program based on WHO criteria and utilizing visualization with acetic acid. Patients who are positive will be offered same-day cryotherapy if indicated or will be referred for biopsy, LEEP and hysterectomy as indicated. The planned patient pool for this study is 1000 women, half of whom will be HIV positive (and thus have a presumed higher incidence of cervical neoplasia).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1000
Inclusion Criteria
  • female, age 30-49, able to give informed consent
Exclusion Criteria
  • pregnancy, gross cervical mass, prior cervical cancer, unable to give informed consent, prior complete hysterectomy, allergic to acetic acid

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence of cervical neoplasia in HIV positive womenup to 12 months

500 HIV positive women will be screened for cervical neoplasia using direct visualization with acetic acid

Prevalence of cervical neoplasia in HIV negative womenup to 12 months

500 HIV negative women will be screened for cervical neoplasia using direct visualization with acetic acid

Secondary Outcome Measures
NameTimeMethod
Treatment of HIV positive women who screen as positiveup to 12 months

Patients who screen positive will be offered same-day cryotherapy, further diagnostic work-up, and further therapeutic options such as LEEP and hysterectomy as clinically indicated.

Treatment of HIV negative women who screen as positiveup to 12 months

Patients who screen positive will be offered same-day cryotherapy, further diagnostic work-up, and further therapeutic options such as LEEP and hysterectomy as clinically indicated.

Trial Locations

Locations (1)

Sihanouk Hospital, St. 134, Sangkat Vealvong, Khan 7 Makara

🇰🇭

Phnom Pehn, Cambodia

Sihanouk Hospital, St. 134, Sangkat Vealvong, Khan 7 Makara
🇰🇭Phnom Pehn, Cambodia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.